One such model developed by Chen et al., 2020 grafted the tumor specific anti-CAIX antibody via disulphide linkages which dissolved under GSH exposure at tumor sites, releasing the loaded DOX into mouse breast cancer cells [97]. The gene discussed is CA9; the disease is neoplasm.